Company Search:
Advanced Search
Sponsored Links
Adverum Biotechnologies Inc Company Snapshot
Adverum Biotechnologies Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adverum Biotechnologies Inc with three other companies in this sector in the United States: Bioxyne Limited (2018 sales of $1.54 million ), Eyegate Pharmaceuticals Inc ($1.65 million of which 100% was Eyecare products), and Cardax Inc ($1.51 million ).

Sales Analysis. Adverum Biotechnologies Inc reported sales of $1.61 million for the year ending December of 2018. This represents a decrease of 12.8% versus 2017, when the company's sales were $1.85 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adverum Biotechnologies Inc
  Stock Performance Chart for Adverum Biotechnologies Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 11.72
(Figures in U.S. Dollars)
1 Week 6.7%   13 Weeks 10.0%  
4 Weeks 69.4%   52 Weeks 261.7%  
Adverum Biotechnologies Inc Key Data:
  Ticker: ADVM Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 1,612,000
(Year Ending Jan 2019).
Employees: 82
  Currency: U.S. Dollars Market Cap: 756,971,899
  Fiscal Yr Ends: December Shares Outstanding: 64,588,046
  Share Type: Common Closely Held Shares: 6,254,547
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.